Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
BlackRock finalises HPS acquisition to launch $190bn private credit platform
BlackRock finalises HPS acquisition to launch $190bn private credit platform BlackRock has completed its acquisition of HPS Investment Partners, significantly expanding its footprint in private credit and establishing a new integrated platform, Private Financing...
Bain and Warner Music launch $1.2bn JV, eye $300m Red Hot Chili Peppers catalogue acquisition
Bain and Warner Music launch $1.2bn JV, eye $300m Red Hot Chili Peppers catalogue acquisition Warner Music and Bain Capital have joined forces in a $1.2bn joint venture aimed at aggressively acquiring music rights, with their first major target being the Red Hot Chili...
Goldman Sachs Alternatives takes stake in AAB as firm targets next growth phase
Goldman Sachs Alternatives takes stake in AAB as firm targets next growth phase Goldman Sachs Alternatives has agreed to acquire leading UK professional services firm AAB from August Equity, in a transaction that underscores growing private equity appetite for scaled,...